Depression
Spravato (Esketamine) for Treatment-Resistant Depression: What Patients Should Know
Spravato is the first new class of antidepressant in 30 years. For patients who haven't responded to standard antidepressants, it offers real hope.
Treatment Options
Expert articles on treatment options from Dr. Mark Agresti, M.D.